Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid Inhalations for Hemoptysis
NCT01496196Phase 3Unknown
- Sponsor
- Meir Medical Center
- Start
- Jan 2012
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in hemoptysis, sponsored by Meir Medical Center. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
hemoptysis
Beyond the preview
Go deeper on NCT01496196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01496196.